In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents

AUTHORS

Tahereh Shokohi 1 , * , Zainab Bandalizadeh 2 , Mohmmad Taghi Hedayati 2 , Sabah Mayahi 2

1 Deptartment of Medical Mycology and Parasitology, Sari Medical School and Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, [email protected], Iran

2 Deptartment of Medical Mycology and Parasitology, Sari Medical School, Mazandaran University of Medical Sciences, Iran

How to Cite: Shokohi T, Bandalizadeh Z, Taghi Hedayati M, Mayahi S. In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents , Jundishapur J Microbiol. Online ahead of Print ; 4(Suppl):19-26.

ARTICLE INFORMATION

Jundishapur Journal of Microbiology: 4 (Suppl); 19-26
Article Type: Research Article

Crossmark

CHEKING

READ FULL TEXT
Abstract

Introduction and objective: Oropharyngeal candidiasis is a relatively common mycotic infection in cancer patients. In vitro susceptibility of oropharyngeal Candida isolates can be useful in selecting the appropriate treatment for the best therapeutic outcome. The aim of this study was to evaluate the in vitro antifungal activity of Candida species against antifungal agents.

Material and methods: In vitro activities of four antifungals were detected in 69 Candida isolates recovered from cancer patients in four university hospitals using the microdilution method described in the CLSI M27-A3 guideline.

Result: Only 12(17.4%) of Candida isolate were resistant to antifungal agents. Three isolates (4.4% included C. albicans, C. glabrata, C. tropicalis, and C. pelliculosa) were resistant to amphotericin B, 5(7.2% included two C. albicans, two C. glabrata, and one C. kefyr) were itraconazole resistant. Two (2.9% include one C. albicans and one C. glabrata) were fluconazole resistant. Caspofungin resistance was detected in two C. infanticola strains which were reported as a clinical isolate for the first time. All Candida isolates (n=69) taken together gave minimum inhibitory concentration (MIC90) value for amphotericin B, fluconazole, itraconazole and caspofungin of 1, 0.25, 32 and 0.25μg/ml, respectively. In total, 18.7% of C. glabrata and 7.8% of C. albicans isolates were fully resistant to both itraconazole and fluconazole.

Conclusion: Caspofungin had activity against oropharyngeal non- albicans Candida species isolates, particularly against those with reduced susceptibility to amphotericin B, fluconazole and itraconazole.

Keywords

Antifungals In vitro susceptibility Candida species Oropharyngeal candidiasis

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: